Pay in 4 interest-free payments of $8.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
DVT's may lead to pulmonary embolism (PE) in knee or hip replacement surgery patients
MEK162 was orally dosed to mice at 3-30 mg/kg once per day
CAS Number: 263707-16-0
but not mTORC2
46(5):483-93
SB525334 - CAS# 356559-20-1 Catalog No.:M6900-2 DVT's may lead to pulmonarySB525334, CAS No. 356559 20 1, is a potent and selective inhibitor of the transforming growth factor beta1 (TGF beta1) receptor, activin receptor like kinase (ALK5). SB525334 inhibited ALK5 kinase activity with an IC(50) of 14. 3 nM and was approximately 4 fold less potent as an inhibitor of ALK4 (IC(50) = 58. 5 nM). SB 525334 was inactive as an inhibitor of ALK2, ALK3, and ALK6 (IC(50) > 10, 000 nM). In cell based assays, SB 525334 (1 microM) blocked
US$ 82.00
US$ 78.00
US$ 154.00
US$ 45.00
US$ 84.00
US$ 94.00
US$ 44.00
US$ 62.00
US$ 144.00
US$ 84.00
US$ 156.00
US$ 38.00
US$ 96.00
US$ 168.00
US$ 148.40
US$ 66.00
US$ 76.00
US$ 42.00